OGB-21501

N/A

Report date: 2022/01/17 17:18:33

Base Information

Drug NameOGB-21501
Drug Alias NameOGB-21501
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionFibroblast growth factor 21 agonistsGlucose-Dependent Insulinotropic Polypeptide Receptor agonistsGlucagon-like peptide 1 receptor agonists +[4] 
TargetsFibroblast growth factor 21Glucose-Dependent Insulinotropic Polypeptide ReceptorGlucagon-like peptide 1 receptor +[4] 
Therapy Area/IndicationsObesityMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOnegene Biotechnology Inc
China Registration ClassN/A

Develop Information

Active CompaniesOnegene Biotechnology Inc
Inactive CompaniesN/A
Active IndicationsObesityMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A